BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35789980)

  • 1. BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1.
    Chen S; Li H; Chen S; Wang B; Zhang K
    Clin Transl Oncol; 2022 Nov; 24(11):2166-2174. PubMed ID: 35789980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1.
    Shtutman M; Baig M; Levina E; Hurteau G; Lim CU; Broude E; Nikiforov M; Harkins TT; Carmack CS; Ding Y; Wieland F; Buttyan R; Roninson IB
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12449-54. PubMed ID: 21746916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
    Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
    Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
    Zhang Y; Kong Y; Ma Y; Ni S; Wikerholmen T; Xi K; Zhao F; Zhao Z; Wang J; Huang B; Chen A; Yao Z; Han M; Feng Z; Hu Y; Thorsen F; Wang J; Li X
    Oncogene; 2021 Feb; 40(8):1425-1439. PubMed ID: 33420375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis.
    Wu L; Zhang D; Zhou L; Pei Y; Zhuang Y; Cui W; Chen J
    EBioMedicine; 2019 Mar; 41():384-394. PubMed ID: 30803933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma.
    Zang J; Hui L; Yang N; Yang B; Jiang X
    Int J Med Sci; 2018; 15(5):447-455. PubMed ID: 29559833
    [No Abstract]   [Full Text] [Related]  

  • 8. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
    Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer.
    Xie J; Ni J; Shi H; Wang K; Ma X; Li W; Peng B
    Cancer Med; 2023 Mar; 12(5):5718-5735. PubMed ID: 36208024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
    Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
    PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA BMI1 Serves as a Potential Target for Diagnosis and Treatment in Esophageal Cancer.
    Zhao Q; Zhu X; Ke JM; Su XY; Yi J; Wu DL; Lin J; Deng ZQ
    Technol Cancer Res Treat; 2021; 20():15330338211033075. PubMed ID: 34278876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
    Gergely JE; Dorsey AE; Dimri GP; Dimri M
    Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29a Inhibits Growth, Migration and Invasion of Melanoma A375 Cells in Vitro by Directly Targeting BMI1.
    Xiong Y; Liu L; Qiu Y; Liu L
    Cell Physiol Biochem; 2018; 50(1):385-397. PubMed ID: 30286469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Xu R; Chen L; Yang WT
    Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
    Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
    J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
    Gong XF; Yu AL; Tang J; Wang CL; He JR; Chen GQ; Zhao Q; He M; Zhou CX
    Exp Cell Res; 2018 Jan; 362(2):378-385. PubMed ID: 29208462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
    Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W
    Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.